Screener
Aurinia Pharmaceuticals AUPH Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Finance lease liabilities, less current portion | 43,943 | 52,322 |
| Deferred tax benefits | 23,128 | — |
| Deferred revenue, less current portion | 7,480 | 12,648 |
| Operating lease liabilities, less current portion | 2,009 | 4,900 |
| Other noncurrent liabilities | 945 | 6,662 |
| Total liabilities | 177,398 | 170,256 |
| Commitments and contingencies (Note 5) | ||
| Shareholders' equity |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's operating lease liabilities?
- Aurinia Pharmaceuticals (AUPH) reported operating lease liabilities of $2.01M in Q2 2026.
- How has Aurinia Pharmaceuticals's operating lease liabilities changed year-over-year?
- Aurinia Pharmaceuticals's operating lease liabilities decreased by 62.3% year-over-year, from $5.33M to $2.01M.
- What is the long-term trend for Aurinia Pharmaceuticals's operating lease liabilities?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's operating lease liabilities has grown at a -8.4% compound annual growth rate (CAGR), from $7.62M to $4.9M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Aurinia Pharmaceuticals's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude